Send us a text

On this episode, Medicare and insurance expert Andy Stansfield joins Dr. Michael Koren to review the differences between traditional Medicare and Medicare Advantage. Andy reveals the intricacies of Medicare's components - Parts A, B, C, and D - and explains how the government collaborates with private insurance companies to manage Medicare Advantage in an effort to promote competition and efficiency. The duo unravel the complexities of traditional Medicare versus Medicare Advantage, highlighting cost and flexibility trade-offs that impact decision-making. 

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

In this episode, Obesity, Lifestyle, and Pediatric Specialist Dr. Randolph Nunez joins Cardiologist and Clinical Researcher Dr. Michael Koren as they discuss the approaches to managing obesity, particularly in children and adolescents. Dr. Nunez talks about Keystone Habits like sleep, and how tackling those habits are the key to sustained weight loss. The doctors discuss the psychological, physical, and biologic processes that can have an effect on weight and the difficulty of willpower. They also talk about new medications, GLP-1 inhibitors, surgical options, and how these ideas intersect with childhood obesity. They finish by talking about the personalized nature of effective weight management strategies. 

Koren's Key Takeaways:

• Willpower varies from person-to-person, day-to-day, and activity-to-activity
• An obesity specialist can help fight "food noise," the amount of time a person thinks about eating
• A key to weight loss is finding out if there are underlying reasons why a person gained weight

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

On this week’s MedEvidence Monday Minute, Dr. Michael Koren and Kevin Geddings discuss the superbowl and how the predictions around the outcome - based on past experiences - were no substitute for knowing how the actual game would turn out. They relate this to clinical trials, where a hypothesis can sound sensible and have logical underpinnings, but a randomized, controlled clinical trial is needed to test that hypothesis and see if the outcome matches our predictions.

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

Join Pulmonologist Dr. Mitchell Rothstein and Allergist and Immunologist Dr. Steve Dorman as they explore the violent activity that can project particles at 100 miles an hour out of your mouth: coughing! The doctors explain the varied approaches doctors take when trying to find the cause of a cough and what happens inside the body to turn a cough from productive to chronic. They explore things that can stimulate a coughing event and review what medications are currently approved for chronic cough. Finally, the two doctors discuss the possibility of new medications being developed currently in clinical trials. Stay tuned and don’t miss this episode.

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

Technology like Artificial Intelligence (AI) is being integrated more and more into our lives. It's fast, convenient, and can be used at home to gather more health data than ever. But how do we know if the benefits of these technologies outweigh potential risks and pitfalls? 

Dr. Mike Hafran joins Dr. Michael Koren to discuss how clinical trials can and have been used to weigh the risks and benefits of new medicines in the past and how clinical trials need to be applied to emerging healthcare technologies (and newly categorized medicines like cannabis) before they are integrated fully into the healthcare system.

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

This episode focuses on the FDA's approval of Journavx, a new class of pain medication that offers an alternative to traditional narcotics like OxyContin. Listeners learn about the significance of clinical trials, patient involvement, and the evolution of pain management strategies while emphasizing the need for informed discussions with healthcare providers. 
• Introduction to Jernovex and its pain management potential 
• Importance of clinical trials in drug development 
• Discussion on the practical implications for patients 
• Shift in medical policy around narcotic use 
• Overview of phase four trials and their significance 
• Resources offered by MedEvidence for reliable health information 
• Call to action for patients to engage with their healthcare providers regarding new treatment options

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

In this second and final part of this series, Dr. Michael Koren and Dr. Seth Baum discuss the importance of patient retention in cardiovascular clinical trials. They highlight how participants in these trials, even those on placebos, often experience better health outcomes due to increased medical attention. They stress the need for clear communication at the outset, proper participant selection, and continued engagement through education and personal interactions. Dropping out of a trial can negatively impact the study’s validity and broader medical advancements. 

Dr. Koren's Key takeaways

• Patient retention is critical for good clinical trial data
• Many patients experience medical benefits even when taking a placebo
• Beyond personal benefits, clinical trials can help millions or billions of people

Recorded 11/11/2024

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

The trajectory for those with cardiovascular disease has changed drastically in the past few decades. Cardiologists Michael Koren and Seth Baum discuss the amazing 60% drop in cardiovascular mortality since the 1980's and the worrying rebound in heart-related mortality starting around 2012. They dissect various influences for both of these trends, including changes in diet, a widespread drop in medical compliance, and wavering public opinion on heart medicines like statins.

Dr. Koren and Dr. Baum then dive into some potential ways to tackle the worrying recent trend, including education and new medicines which may be easier and more effective. They explain how clinical trials are the gold standard for how scientists and researchers gather data about medicine and heart care

Dr. Koren's Key takeaways:

• Cardiovascular deaths dropped 60% since 1980, but have risen since 2012
• There have been recent increases in related conditions like obesity and diabetes
• Follow doctor recommendations, especially those that relate to your heart!

Recorded 11/11/2024

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

Dr. Michael Koren reflects on his interview with Dr. Anthony Fauci with Kevin Geddings. This episode explores Dr. Fauci's history in public health and his life after exiting the government sphere. Dr. Koren and Kevin Geddings  also highlight the importance of acknowledging uncertainties in science, and how other fields don't always have the same clarity and transparency as medicine. 

A key takeaway is the MedEvidence! approach: identifying what is known, unknown, and how to learn more. This honest perspective underscores the value of evidence-based medicine, public trust in healthcare, and the critical role of public participation in research trials. .

Be sure to also listen to Dr. Koren's interview with Dr. Fauci in our podcast Ep. 260

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

Join Dr. Anthony Fauci and Dr. Michael Koren as they discuss the public health events that have punctuated Dr. Fauci's life. The doctors discuss the difficulties of the HIV epidemic in the 1980's and how Dr. Fauci's early career decision to pursue this emerging threat helped inform and prepare him for the COVID-19 pandemic. Doctors Koren and Fauci wade through the myriad controversies surrounding the public health response to the COVID-19 pandemic; from its origins, the importance of vaccines, and the balance of public health and individual rights. Finally, the two speak about the difficulty of public health communication during an evolving situation and the importance of high-quality data from sources like clinical trials.

Koren's Key Takeaways:

• Scientific integrity and the credible medical information are critical to public health
• Previous healthcare crises can help inform current and future ones
• Balancing personal rights and public health mandates is a challenge

Recorded 1/17/2025


Reference:

Moreira Jr, Edson D., Nicholas Kitchin, Xia Xu, Samuel S. Dychter, Stephen Lockhart, Alejandra Gurtman, John L. Perez et al. "Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine." New England journal of medicine 386, no. 20 (2022): 1910-1921. https://www.nejm.org/doi/full/10.1056/NEJMoa2200674


COVID update: the AstraZeneca antibody vaccine was just approved overseas. Interested in the next generation of oral COVID vaccine? Contact ENCORE Research group at (904) 760-0166 or visit ENCOREdocs.com

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!